Proteome Sciences, Icon Ink Biomarker Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Irish biotech and pharmaceutical services firm Icon and Proteome Sciences have agreed to collaborate to offer a biomarker discovery solution to assess new candidate drugs, Icon said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.